三葉草生物-B(02197.HK)授出573.25萬份購股權
格隆匯12月16日丨三葉草生物-B(02197.HK)發佈公吿,2022年12月15日,公司根據首次公開發售後購股權計劃的條款向46名購股權承授人授出合共573.25萬份購股權,待接納。所授出的購股權的行使價每股3.83港元,購股權有效期自授出日期起10年。
同日,公司根據受限制股份單位計劃向35名受限制股份單位承授人授出合共168.7萬個受限制股份單位。168.7萬個受限制股份單位代表168.7萬股相關股份,約佔公司截至該公吿日期已發行股本0.13%。根據聯交所於授出日期發出的每日報價表所示每股股份收市價3.240港元計算,授予受限制股份單位承授人的168.7萬個受限制股份單位的市值最高為546.588萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.